Authors: Saif, MW Wilson, RH Harold, N Keith, B Dougherty, DS Grem, JL

Citation: Mw. Saif et al., Peripheral neuropathy associated with weekly oval 5-fluorouvacil, leucovorin and eniluracil, ANTI-CANC D, 12(6), 2001, pp. 525-531

Authors: Fisher, E Rudick, RA Cutter, G Baier, M Miller, D Weinstock-Guttman, B Mass, MK Dougherty, DS Simonian, NA

Citation: E. Fisher et al., Relationship between brain atrophy and disability: an 8-year follow-up study of multiple sclerosis patients, MULT SCLER, 6(6), 2000, pp. 373-377

Authors: Rudick, RA Cookfair, DL Simonian, NA Ransohoff, RM Richert, JR Jacobs, LD Herndon, RM Salazar, AM Fischer, JS Granger, CV Goodkin, DE Simon, JH Bartoszak, DM Bourdette, DN Braiman, J Brownscheidle, CM Coats, ME Cohan, SL Dougherty, DS Kinkel, RP Mass, MK Munchsauer, FE O'Reilly, K Priore, RL Pullicino, PM Scherokman, BJ Wende, K Weinstock-Guttman, B Whitham, RH

Citation: Ra. Rudick et al., Cerebrospinal fluid abnormalities in a phase III trial of Avonex (R) (IFN beta-1a) for relapsing multiple sclerosis, J NEUROIMM, 93(1-2), 1999, pp. 8-14

Authors: Goodkin, DE Priore, RL Wende, KE Campion, M Bourdette, DN Herndon, RM Fischer, JS Jacobs, LD Cookfair, DL Rudick, RA Richert, JR Salazar, AM Granger, CV Simon, JH Alam, JJ Bartoszak, DM Braiman, J Brownscheidle, CM Coats, ME Cohan, SL Dougherty, DS Kinkel, RP Mass, MK Munschauer, FE Pullicino, PM Scherokman, BJ Weinstock-Guttman, B Whitham, RH

Citation: De. Goodkin et al., Comparing the ability of various compositive outcomes to discriminate treatment effects in MS clinical trials, MULT SCLER, 4(6), 1998, pp. 480-486